Advanced NanoTherapies (ANT) Secures $4M Strategic Investment to Accelerate Clinical Development of SirPlux Duo Drug-Coated Balloon (DCB) for Treating de novo Coronary Artery Disease (CAD)
- Tuesday, August 22, 2023, 7:02
- Finance
- Add a comment
Milestone achieved as company announces successful enrollment of ten patients in its First-In-Human (FIH) Trial, ADVANCE-DCB LOS GATOS, Calif., Aug. 22, 2023 /PRNewswire/ — Advanced NanoTherapies Inc. (ANT), a clinical-stage medical device company committed to solving the most…
About the Author
adminasapcorp has written 39584 stories on this site.